Question 1

What is the catalog number for C16orf9 (C16orf9, DKFZp761D0211, FLJ32603, gs19)?

Accepted Answer

The catalog number for C16orf9 (C16orf9, DKFZp761D0211, FLJ32603, gs19) is 469919.

Question 2

What sizes are available for C16orf9 (C16orf9, DKFZp761D0211, FLJ32603, gs19)?

Accepted Answer

C16orf9 (C16orf9, DKFZp761D0211, FLJ32603, gs19) is available in the following size(s): 50 µg.

Question 3

Is C16orf9 (C16orf9, DKFZp761D0211, FLJ32603, gs19) in stock?

Accepted Answer

C16orf9 (C16orf9, DKFZp761D0211, FLJ32603, gs19) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

Question 5

Can I return this product if I ordered the wrong one?

Accepted Answer

As a consumer, you have a 14-day right of withdrawal from receipt under EU consumer protection law, submitted via our withdrawal/cancellation request form. Note this applies to unused, undamaged products, and doesn’t override the expiry/storage conditions on performance-based claims.

Question 6

Is this product tested for endotoxin levels?

Accepted Answer

Endotoxin testing status is noted on the datasheet where applicable, particularly for recombinant proteins intended for cell-based or functional assays. If this isn’t listed and you need confirmation, contact support with the catalogue number.

C16orf9 (C16orf9, DKFZp761D0211, FLJ32603, gs19)

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

CD22 / BL-CAM (B-Cell Marker) (RFB4), CF488A conjugate, 0.1mg/mL

Bcl-2 (Apoptosis & Follicular Lymphoma Marker) (rBCL2/782), CF405S conjugate, 0.1mg/mL

Involucrin (Squamous Cell Terminal Differentiation Marker) (rIVRN/827), CF568 conjugate, 0.1mg/mL

Anti-OXCT2 Antibody Picoband®, Cy3 Conjugate

TIGIT / VSTM3 / VSIG9 (Immune Checkpoint for Cancer) (TIGIT/3106), CF647 conjugate, 0.1mg/mL

Anti-MEF2A Antibody Picoband®